Literature DB >> 8195921

Alzheimer's disease: pathophysiology and the hope for therapy.

R A Brumback1, R W Leech.   

Abstract

The approximately 4.5 million Alzheimer's disease victims in the United States represent a major public health problem resulting in annual expense topping $100 billion, with the Oklahoma share being about $500 million. This problem will be even larger as the baby boomer generation reaches the ages of maximum prevalence of Alzheimer's disease. Research has provided only meager insights into this devastating disease, but has permitted some rational hypotheses concerning potential treatment. Still, the definitive diagnosis of Alzheimer's disease requires pathologic confirmation. In interviews with families following the autopsy, it is apparent that the disease is poorly understood by both the family members and many of the health care workers with which they have dealt. Thus, this review (based upon the questions raised by families and their physicians) examines the currently understood mechanisms and pathogenesis of Alzheimer's disease, the hereditary patterns, and the hope for therapy.

Entities:  

Mesh:

Year:  1994        PMID: 8195921

Source DB:  PubMed          Journal:  J Okla State Med Assoc        ISSN: 0030-1876


  7 in total

1.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

2.  Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

Authors:  I Gozes; O Perl; E Giladi; A Davidson; O Ashur-Fabian; S Rubinraut; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Neuropsychological screening tests in African Americans.

Authors:  V T Lampley-Dallas
Journal:  J Natl Med Assoc       Date:  2001-09       Impact factor: 1.798

4.  Somatosensory responses in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Julia M Stephen; Rebecca Montaño; Christopher H Donahue; John C Adair; Janice Knoefel; Clifford Qualls; Blaine Hart; Doug Ranken; Cheryl J Aine
Journal:  J Neural Transm (Vienna)       Date:  2009-12-15       Impact factor: 3.575

5.  Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

Authors:  I Gozes; A Bardea; A Reshef; R Zamostiano; S Zhukovsky; S Rubinraut; M Fridkin; D E Brenneman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

6.  Impact of Antipsychotics on Geriatric Patients: Efficacy, Dosing, and Compliance.

Authors:  Gerald A. Maguire
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

7.  Perceived needs of African-American caregivers of elders with dementia.

Authors:  V T Lampley-Dallas; J W Mold; D E Flori
Journal:  J Natl Med Assoc       Date:  2001-02       Impact factor: 1.798

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.